A hallucinogenic drug is being trialled for the first time as a potential cure for depression.
Dubbed ‘psychedelic therapy’, the drug being trialled is known for its part in shamanic rituals. Shamanism is a religious practice historically associated with indigenous and tribal societies.
The trial hopes to find an alternative solution for depression sufferers who don’t respond to typical antidepressants issued by doctors.
The substance, known as N,N-Dimethyltryptamine (DMT), is being offered to a group of people with moderate to severe cases of depression, Yahoo! News reports. The treatment will then be followed with talking therapy.
It’s hoped the trial will outline whether the compound can be given as a one-off treatment or as part of a course. Those taking part will be followed for at least six months to track the benefits.
Carol Routledge, the chief scientific officer of Small Pharma, the…